Sunshine Biopharma (SBFM) Accumulated Expenses (2012 - 2021)

Sunshine Biopharma's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $48287.0 for Q4 2021.

• Quarterly Accumulated Expenses rose 213.71% year-over-year to $48287.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $48287.0 (up 213.71% YoY) and the FY2021 annual result came in at $48287.0, up 213.71% from the prior year.
• Accumulated Expenses was $48287.0 for Q4 2021 at Sunshine Biopharma, down from $84945.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $84945.0 in Q3 2021 and bottomed at $1171.0 in Q1 2017.
• A 5-year average of $29464.0 and a median of $28407.5 in 2018 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2017 — Accumulated Expenses tumbled 67.11% — and 2018, when it surged 1772.25%.
• Sunshine Biopharma's Accumulated Expenses stood at $9215.0 in 2017, then climbed by 0.82% to $9291.0 in 2018, then surged by 66.92% to $15509.0 in 2019, then declined by 0.75% to $15392.0 in 2020, then surged by 213.71% to $48287.0 in 2021.
• Business Quant data shows SBFM's Accumulated Expenses at $48287.0 in Q4 2021, $84945.0 in Q3 2021, and $58712.0 in Q2 2021.